Blume Capital Management, Inc. Bristol Myers Squibb CO Transaction History
Blume Capital Management, Inc.
- $431 Million
- Q1 2025
A detailed history of Blume Capital Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Blume Capital Management, Inc. holds 2,007 shares of BMY stock, worth $93,827. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,007
Previous 2,204
8.94%
Holding current value
$93,827
Previous $124,000
1.61%
% of portfolio
0.03%
Previous 0.03%
Shares
15 transactions
Others Institutions Holding BMY
# of Institutions
2,801Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$8.95 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.42 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.05 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.43 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.11 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.4B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...